Crown Equity Holdings Inc. (OTCPK:CRWE)
CRWE just recently announced that it has launched its crwenewswire.fr website to provide news in France's native language. CRWE had previously launched its German website crwenewswire.de and is launching CRWE's Canadian website crwenewswire.ca shortly.
"The new website is one step in many towards CRWE's goal of expanding its footprint internationally, " commented Kenneth Bosket, President and CEO of CRWE "Our goal for 2010 is to have all CRWE's clients' press releases, articles and news content published in every major financial country's native language, as well as within cities of every state of our country," stated Mr. Bosket.
In other CRWE news, CRWE announces that its sales this year have already surpassed $1,000,000. This compares to $232,510 for the three quarters ending September 30, 2009 and $ 659,907 total sales for the year 2009.
"Based on our sales to date, we had more than 4 times the sales for the same period last year and are 34% ahead of last year's total sales," commented Kenneth Bosket, President and CEO of CRWE. "Our growth in sales along with our investments in infrastructure and people give the company a basis for supporting future growth of the magnitude we have seen so far this year," stated Bosket.
CRWE has expanded its internet footprint internationally to include the following 19 countries: Argentina, Australia, Brazil, Canada, China, France, Germany, Hong Kong, India, Ireland, Italy, Japan, Korea, Mexico, New Zealand, Singapore, Spain, Taiwan and the UK.
CRWE is a consulting organization which provides and assists small business owners with the knowledge required in taking their company public, and has re-focused CRWE's primary vision with its aligned group of independent website divisions to providing media advertising services, as a worldwide online media advertising publisher, dedicated to the distribution of quality branding information, as well as search engine optimization for its clients.
To learn more about CRWE visit: http://www.crownequityholdings.com
Baxter International Inc. (NYSE: BAX) announced the formation of a new Medical Products business, combining the company’s Renal and Medication Delivery businesses into a single global business unit. This new business brings together two organizations that can leverage many capabilities and requirements across product development, supply chain, manufacturing and regulatory affairs.
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.
CVS Caremark Corporation (NYSE: CVS) stockcall.com/ offers investors comprehensive research on the drug stores industry and has completed analytical research on Rite Aid Corp. (NYSE:RAD) and CVS Caremark Corporation (NYSE:CVS).It has been a rocky year for many in the drug store industry. Reforms to the healthcare industry alongside the sluggish economy have led to mixed financial readings so far this year, with many companies posting declines in earnings. Despite lower sales figures industry players are investing heavily in their futures and currently footing the bill for starting up new programs. As the healthcare and consumer landscape is changing around them, companies are looking to expand their services to stay ahead in the long-term.
CVS Caremark Corporation operates as a pharmacy services company in the United States. It operates in two segments, Pharmacy Services and Retail Pharmacy. The Pharmacy Service segment provides a range of prescription benefit management services, including mail order pharmacy services, specialty pharmacy services, plan design and administration, formulary management, and claims processing.
Abbott Laboratories (NYSE: ABT) begins trading without the right to receive a $0.44 dividend declared Sept. 16. Investors had to own the stock before October 13 to receive the payout, which traders deduct from the company's share price on the ex-dividend date.
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. It operates in four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.